Do we over-diagnose ADHD in North America? A critical review and clinical recommendations

J Clin Psychol. 2022 Dec;78(12):2363-2380. doi: 10.1002/jclp.23348. Epub 2022 Mar 23.

Abstract

There has been a marked increase in the prevalence of attention-deficit/hyperactivity disorder (ADHD) in the last 25 years in North America. Some see this trend as positive and believe that it reflects a better identification of ADHD and even think that the disorder is still under-diagnosed. Others, however, contend that ADHD is over-diagnosed. To help mental health clinicians to maintain an informed and nuanced perspective on this debate, this critical review aims to (1) summarize empirical results on factors that might contribute to increase the number of ADHD diagnoses and (2) propose clinical recommendations coherent with these findings to improve clinical practices for ADHD assessment and treatment. We conclude that artifactual factors such as current formulation of diagnostic criteria, clinical practices, and inordinate focus on performance, which is rampant in North America, likely contribute to inflated prevalence rates.

Keywords: DSM-5; attention deficit/hyperactivity; diagnosis; over-diagnosis; over-medicalization; prevalence.

Publication types

  • Review

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / diagnosis
  • Attention Deficit Disorder with Hyperactivity* / epidemiology
  • Attention Deficit Disorder with Hyperactivity* / psychology
  • Diagnostic and Statistical Manual of Mental Disorders
  • Humans
  • North America / epidemiology
  • Overdiagnosis
  • Prevalence